Skip to main content
Premium Trial:

Request an Annual Quote

NanoString, OnRamp to Create Cloud-Based Analysis Tools for nCounter Data

NEW YORK – NanoString Technologies and OnRamp Bioinformatics said today that they are collaborating in the development of new cloud-based analysis tools for data generated on NanoString's nCounter system.

The new nCounter analysis capability is being built into ROSALIND, OnRamp's cloud-based analysis suite, which facilitates data visualization, exploration, and collaboration.

According to the firms, three of the new tools are being made available immediately for early access by COVID-19 researchers performing critical host-response studies. OnRamp said it recently launched a program called the Coronavirus Community, where participating scientists are provided with free access to ROSALIND. NanoString announced the availability of a beta panel spike in for COVID-19 research in April, and said it now has over 50 customers utilizing the reagents in their research.

As they move forward, the companies said they plan to translate other popular features of NanoString's existing nSolver analysis software to function within ROSALIND's cloud-based collaborative structure. They also evaluating opportunities for joint development of new analysis solutions.

"This partnership represents a shared vision of accelerating research by making gene expression analysis simple and broadly accessible," Joe Beechem, NanoString's chief scientific officer, said in a statement.

Financial terms of the deal were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.